BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  Deciphera Pharmaceuticals Announces Initiation Of Phase 1 Cancer Trial For Altiratinib (DCC-2701) MET/TIE2/VEGFR/TRK Kinase Inhibitor For Solid Tumors

  May 30, 2014

   · 

  1 min read
• BioMidwest

  Biothera To Present Predictive Biomarker Data At American Society of Clinical Oncology For Cancer Immunotherapy Imprime PGG

  May 30, 2014

   · 

  1 min read
• Drug Development

  Threshold Pharmaceuticals, Inc. Announces Data From Ongoing Phase 1/2 Trial Of TH-302 Plus Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma

  May 30, 2014

   · 

  9 min read
• Bio NC

  INC Research, Inc. Debuts New Interactive Website

  May 30, 2014

   · 

  2 min read
• SANUWAVE, Inc. To Present At The Accredited Members Spring 2014 Small Cap/Micro Cap Conference

  May 30, 2014

   · 

  1 min read
• Drug Development

  NewLink Genetics Dorgenmeltucel-L Hyperacute Immunotherapy For Melanoma Demonstrates Clinical Efficacy With Tumor Regression And Immune Activation

  May 30, 2014

   · 

  7 min read
• Drug Development

  AngioChem Presents Positive Data On ANG1005 In Brain Mets, Launches Phase 2, Gets Orphan Drug/Fast Track

  May 30, 2014

   · 

  4 min read
• Business

  Hamamatsu Corporation Announces The Completion Of A New Facility For The Development And Mass Production Of MOEMS-Based Products

  May 30, 2014

   · 

  1 min read
• Business

  QIAGEN N.V. And Eli Lilly and Company Collaborate To Co-Develop Companion Diagnostics For Simultaneous Analysis Of Dna And Rna Biomarkers In Common Cancers

  May 30, 2014

   · 

  5 min read
• FDA

  Bayer HealthCare Receives EU Approval For Nexavar (Sorafenib) For The Treatment Of Differentiated Thyroid Cancer

  May 30, 2014

   · 

  5 min read